AcuCort

AcuCort is a Swedish biotechnology company focused on developing and commercializing innovative oral film-based drugs for acute medical conditions. The company's lead product, Zeqmelit (formerly ISICORT), is a fast-dissolving oral film containing dexamethasone, designed for the treatment of acute allergic reactions, croup, and chemotherapy-induced nausea and vomiting. By utilizing its proprietary SpotOn technology, AcuCort provides a patient-friendly alternative to traditional tablets and injections, particularly beneficial for patients with swallowing difficulties. Zeqmelit has received market approval in several European countries and is currently being rolled out commercially. AcuCort aims to improve patient quality of life through rapid-acting and easy-to-administer treatments.